Suchergebnisse - "An, Jihyun"

PubPharm (144)

21

Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas

enthalten in: Hepatology (Baltimore, Md.) | 2022

von An, J. | Kim, D. | Oh, B. | +16

22

Reply : Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

enthalten in: Clinical and molecular hepatology | 2022

von An, J. | Shim, J.

CommentOn: Clin Mol Hepatol. 2022 Jan;28(1):67-76. - PMID 34637612

23

The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma

enthalten in: Journal of liver cancer | 2022

von An, J. | Kang, H. | Yu, E. | +2

24

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

enthalten in: Clinical and molecular hepatology | 2022

von An, J. | Kim, H. | Kim, S. | +4

CommentIn: Clin Mol Hepatol. 2022 Apr;28(2):267-268. - PMID 35038817

25

On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Huang, C. | Jang, T. | Jun, D. | +22

26

Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno‐oncology : A network meta‐analysis of randomized sorafenib‐controlled trials

enthalten in: Hepatology communications | 2022

von An, J. | Han, S. | Kim, H. | +1

27

Comprehensive characterization of viral integrations and genomic aberrations in HBV‐infected intrahepatic cholangiocarcinomas

enthalten in: Hepatology | 2022

von An, J. | Kim, D. | Oh, B. | +16

28

Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old) : A systematic review and meta‐analysis

enthalten in: Journal of Viral Hepatitis | 2022

von Lee, J. | Ahn, S. | Yim, S. | +5

29

Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers : A 35,000‐Korean outcome study

enthalten in: Journal of Viral Hepatitis | 2022

von Lim, J. | Lee, J. | An, J. | +4

30

On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients

enthalten in: Liver International | 2022

von Huang, C. | Jang, T. | Jun, D. | +22